KEGG   DISEASE: alpha-Mannosidosis
Entry
H00139                      Disease                                
Name
alpha-Mannosidosis
  Supergrp
Glycoproteinoses [DS:H00422]
Lysosomal storage disease [DS:H01425]
Description
Alpha-mannosidosis is an autosomal recessive lysosomal storage disorder caused by deficient activity of alpha-mannosidase in glycoprotein catabolism. The enzymatic defect results in the accumulation of mannose-rich oligosaccharides in many organs. Alpha-mannosidosis is characterized by immune deficiency, facial and skeletal abnormalities, hearing impairment, and mental retardation. The disorder has been described as two distinct phenotypes: a severe form with hepatomegaly and early death following severe infections (type 1) and a mild form with hearing loss and mental retardation (type 2).
Category
Inherited metabolic disorder, Lysosomal disease
Brite
Human diseases in ICD-11 classification [BR:br08403]
 05 Endocrine, nutritional or metabolic diseases
  Metabolic disorders
   Inborn errors of metabolism
    5C56  Lysosomal diseases
     H00139  alpha-Mannosidosis
Pathway
hsa04142  Lysosome
hsa00511  Other glycan degradation
Gene
MAN2B1 [HSA:4125] [KO:K12311]
Drug
Velmanase alfa [DR:D11024]
Other DBs
ICD-11: 5C56.21
ICD-10: E77.1
MeSH: D008363
OMIM: 248500
Reference
  Authors
Malm D, Nilssen O
  Title
Alpha-mannosidosis.
  Journal
Orphanet J Rare Dis 3:21 (2008)
DOI:10.1186/1750-1172-3-21
Reference
  Authors
Sun H, Wolfe JH
  Title
Recent progress in lysosomal alpha-mannosidase and its deficiency.
  Journal
Exp Mol Med 33:1-7 (2001)
DOI:10.1038/emm.2001.1
Reference
  Authors
Michalski JC, Klein A
  Title
Glycoprotein lysosomal storage disorders: alpha- and beta-mannosidosis, fucosidosis and alpha-N-acetylgalactosaminidase deficiency.
  Journal
Biochim Biophys Acta 1455:69-84 (1999)
DOI:10.1016/S0925-4439(99)00077-0
LinkDB

» Japanese version

DBGET integrated database retrieval system